Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
about
The effectiveness and cost-effectiveness of inpatient specialist palliative care in acute hospitals for adults with advanced illness and their caregiversIntegrated Palliative Care and Oncologic Care in Non-Small-Cell Lung CancerHospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000-2011The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in TaiwanElderly patients hospitalized in the ICU in France: a population-based study using secondary data from the national hospital discharge database.Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: a 3-year retrospective studyTrends in Advance Care Planning in Patients With Cancer: Results From a National Longitudinal Survey.Does an increase in visits to general practice indicate a malignancy?The health care experience of patients with cancer during the last year of life: Analysis of the SEER-CAHPS data set.Geographic Variation of Hospice Use Patterns at the End of LifeCritical Care Implications of the Affordable Care Act.Emergency Care Use and the Medicare Hospice Benefit for Individuals with Cancer with a Poor PrognosisPhysician Characteristics Strongly Predict Patient Enrollment In HospiceFamily Perspectives on Aggressive Cancer Care Near the End of Life.Racial/Ethnic Differences in Inpatient Palliative Care Consultation for Patients With Advanced CancerTreatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients.Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care.Using Technology to Create a More Humanistic Approach to Integrating Palliative Care into the Intensive Care Unit.Why are patients with blood cancers more likely to die without hospice?Retrospective evaluation of palliative care and hospice utilization in hospitalized patients with metastatic breast cancer.National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.Palliative care for terminally ill patients in the intensive care unit: Systematic review and metaanalysis.Effect of Primary Care Involvement on End-of-Life Care Outcomes: A Systematic Review.Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.End-of-Life Care Patterns at a Community Hospital.Resource Use and Medicare Costs During Lay Navigation for Geriatric Patients With Cancer.Variations Among Physicians in Hospice Referrals of Patients With Advanced Cancer.Family Perspectives on Hospice Care Experiences of Patients with Cancer.A Longitudinal Analysis of Site of Death: The Effects of Continuous Enrollment in Medicare Advantage Versus Conventional Medicare.The rise of concurrent care for veterans with advanced cancer at the end of life.Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.Associations Between End-of-Life Cancer Care Patterns and Medicare ExpendituresUtilization and trends in palliative therapy for stage IV pancreatic adenocarcinoma patients: a U.S. population-based study.Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare.Beyond Enrollment: Providing the Highest-Quality Care within Hospice.Cost savings associated with expanded hospice use in Medicare.Impact of home-based, patient-centered support for people with advanced illness in an open health system: A retrospective claims analysis of health expenditures, utilization, and quality of care at end of life.Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer.Determinants of Palliative Care Utilization Among Patients Hospitalized With Metastatic Gastrointestinal Malignancies.
P2860
Q24187525-B834767E-F7AF-4989-AEE1-2C461C27C6BEQ26749199-74511B22-7DB8-499F-A24C-36E66EB9AE4DQ31063536-1AD25EC7-E6F7-45ED-9853-5D3F08C86B42Q35749583-A15FA27C-F2E1-4C6D-9907-AD423995524DQ35788241-D55D221E-22AA-4EDA-A233-550C0A68D0A0Q35879925-233FC629-966B-4DDC-B6D0-93E7BAAC77BEQ35946753-E1373A1E-D4EE-4B1C-AA50-25ABCEE1150FQ35956209-AF09FBEC-88B9-4819-B001-1B4548860658Q36085379-8F92F375-7178-48FA-827A-B6B8EE092655Q36139825-CE66B1AF-0733-4706-A2FE-BC8E76D9DB83Q36417467-89F24F18-7ED2-4103-AA6E-66E62E7933A9Q36609620-7FC1A114-4E73-47A6-B11C-FB84C7650494Q36716711-0B2BA9F0-8259-44C3-9BF3-0B664EFF2FDAQ36856684-C46EFEE2-CD9E-49F2-8CEE-4250813511B6Q37033648-A7E40CBC-F148-486D-BDDD-E82041A18CF2Q37163611-58DFC799-B532-4B1C-8D72-BF2BCA4287EFQ38520091-EA509BAA-B50C-4A21-B361-A1D73AF75A45Q38586530-EC4A7418-8E0D-4FDD-8B72-D61EFD74843AQ38645463-2F0A41CC-859A-4BC6-B1D8-6935FB122BF2Q38764738-D9EFB01C-C936-4E21-A28F-D4AD104048BDQ38775803-10BB1CEC-DEEA-4390-910B-D90B7D40BBE2Q38837586-BE0386CD-0FA0-4EDE-AA1A-6689F3CD1A8DQ38909346-4311980E-4158-46DF-966E-2389D1E5ECEAQ38934464-C5373ED7-3E77-494F-B605-5C4E06EF61CDQ38975352-6A9616EB-448B-44D6-BE00-DDDBCC98B19EQ38978301-BCE9AC0C-891F-4526-AC2F-6B798E6EC1E7Q38997278-4CD8A291-F612-4AF1-937A-82C52513EDC1Q39145297-99DBAC65-A0BE-4418-9279-4C7E516C2727Q39162503-872DE39A-82D9-4477-B5EB-4E4736B79726Q39756169-C5DF3023-492F-42E3-AC84-1CB095C98AE5Q40208962-216AEEE4-BB08-490D-8397-71668F1B5B5EQ40464625-68D7A600-9BC5-47C7-9ADF-76CF3562D166Q40633704-7CE784EA-C529-4174-AAC6-DC73FB53D235Q41598652-6EA1E5FC-EB96-46CD-8442-61770D1E4EC1Q42023721-2BB8A2E6-522A-45B3-8FD2-D370BCC0D4EBQ42355129-71C86226-8BF4-4DB5-981F-0EC2EE35721CQ42563310-584D2699-56EE-4046-9F1E-0699801D8F52Q46091501-5D088F45-75D9-44B7-BEA0-4FB96419421CQ46148825-9BD4C102-589C-4BAB-9381-AE2FBAF959DBQ46284746-0C861AE9-AF03-43DF-8FBD-C30E3B03BC74
P2860
Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Association between the Medica ...... ts with poor-prognosis cancer.
@ast
Association between the Medica ...... ts with poor-prognosis cancer.
@en
Association between the Medica ...... ts with poor-prognosis cancer.
@nl
type
label
Association between the Medica ...... ts with poor-prognosis cancer.
@ast
Association between the Medica ...... ts with poor-prognosis cancer.
@en
Association between the Medica ...... ts with poor-prognosis cancer.
@nl
prefLabel
Association between the Medica ...... ts with poor-prognosis cancer.
@ast
Association between the Medica ...... ts with poor-prognosis cancer.
@en
Association between the Medica ...... ts with poor-prognosis cancer.
@nl
P2093
P2860
P356
P1476
Association between the Medica ...... ts with poor-prognosis cancer.
@en
P2093
David M Cutler
Francesca Dominici
Samer Abujaber
Susan Block
P2860
P304
P356
10.1001/JAMA.2014.14950
P407
P577
2014-11-01T00:00:00Z